Showing 26 - 50 of 1,441
4-Factor PCC in DOAC-associated Intracranial Hemorrhage
Recruiting
- Intracranial Hemorrhage
- Use of fixed-dosed 4F-PCC
-
Dallas, TexasMethodist Dallas Medical Center
Oct 17, 2023
Hepatorenal Syndrome at Methodist Dallas Medical Center
Recruiting
- Hepatorenal Syndrome
- Hepatorenal Syndrome outcome in Patients at Methodist Health systems
-
Dallas, TexasLiver Institute of Methodist Dallas Medical Center
Oct 18, 2023
Rib Fracture Cryoanalgesia
Recruiting
- Pain Management Improvement
- ioveraº system
-
Dallas, TexasMethodist Dallas Medical Center
Oct 17, 2023
Carcinoma, Hepatocellular, Liver Cancer, Liver Cirrhosis Trial in United States (GALAD, Liver Ultrasound with or without AFP)
Not yet recruiting
- Carcinoma, Hepatocellular
- +3 more
- GALAD
- Liver Ultrasound with or without AFP
-
Los Angeles, California
- +9 more
Oct 18, 2023
Stroke, Fatigue Trial in Dallas (Anodal transcranial direct current stimulation, Sham transcranial direct current stimulation)
Not yet recruiting
- Stroke
- Fatigue
- Anodal transcranial direct current stimulation
- Sham transcranial direct current stimulation
-
Dallas, TexasTexas Woman's University
Oct 12, 2023
Liver Transplant Trial in United States (CMV-MVA Triplex, Placebo for CMV-MVA Triplex)
Not yet recruiting
- Liver Transplant
- CMV-MVA Triplex
- Placebo for CMV-MVA Triplex
-
Redwood City, California
- +16 more
Oct 10, 2023
Laryngeal Carcinoma Trial in Dallas (LT-SABR, IMRT)
Not yet recruiting
- Laryngeal Carcinoma
- LT-SABR
- IMRT
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Oct 6, 2023
PET/MR for Characterization of Renal Masses (RMs)
Recruiting
- Renal Tumor
- +2 more
- 2-Deoxy-2-[18F]fluoroglucose Positron Emission Tomography/Magnetic Resonance Imaging
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Oct 5, 2023
The Longitudinal Study of Stimulant Use Disorder
Not yet recruiting
- Stimulant Use
- +2 more
-
Dallas, TexasUT Southwestern Medical Center
Oct 3, 2023
Ewing Sarcoma, Ewing Sarcoma of Bone, Ewing Sarcoma of Soft Tissue Trial in United States (FoundationOne Liquid CDx)
Recruiting
- Ewing Sarcoma
- +6 more
- FoundationOne Liquid CDx
-
Los Angeles, California
- +14 more
Oct 5, 2023
Type 2 Diabetes Trial in Worldwide (Cagrilintide, Semaglutide, Placebo cagrilintide)
Not yet recruiting
- Type 2 Diabetes Mellitus
- Cagrilintide
- +3 more
-
Birmingham, Alabama
- +331 more
Sep 26, 2023
Chronic Pain Trial in West Haven, Bedford, Dallas (Veteran ACT for Chronic Pain (VACT-CP), Online Pain School)
Not yet recruiting
- Chronic Pain
- Veteran ACT for Chronic Pain (VACT-CP)
- Online Pain School
-
West Haven, Connecticut
- +2 more
Sep 29, 2023
COVID-19, Infectious Disease, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in United States (RQ-001, Placebo)
Recruiting
- COVID-19
- +3 more
- RQ-001
- Placebo
-
Cullman, Alabama
- +8 more
Sep 28, 2023
Heart Failure, Diastolic, Heart Failure With Preserved Ejection Fraction Trial in Durham, Dallas (AAV1/SERCA2a)
Recruiting
- Heart Failure, Diastolic
- Heart Failure With Preserved Ejection Fraction
- AAV1/SERCA2a
-
Durham, North Carolina
- +1 more
Sep 23, 2023
Pulmonary Embolism Trial in Germany, United States (FlowTriever System, Anticoagulation Agents)
Not yet recruiting
- Pulmonary Embolism
- FlowTriever System
- Anticoagulation Agents
-
Birmingham, Alabama
- +32 more
Sep 20, 2023
Multiple Myeloma Trial in Worldwide (idecabtagene vicleucel, Lenalidomide, Fludarabine)
Not yet recruiting
- Multiple Myeloma
- idecabtagene vicleucel
- +3 more
-
Gilbert, Arizona
- +107 more
Sep 26, 2023
Prostate Adenocarcinoma Trial in Dallas (68-Ga PSMA11)
Not yet recruiting
- Prostate Adenocarcinoma
- 68-Ga PSMA11
-
Dallas, TexasUT Southwestern Medical Center
Sep 12, 2023
Expanded Population Health Model Evaluation
Recruiting
- Chronic Disease
- Quality of Life
- Expanded Population Health Model
-
Dallas, TexasBaylor Scott & White Health and Wellness Center
Sep 18, 2023
Lung Transplant Trial in Canada, United States (Tocilizumab, Placebo for Tocilizumab)
Not yet recruiting
- Lung Transplant
- Tocilizumab
- Placebo for Tocilizumab
-
Phoenix, Arizona
- +16 more
Sep 8, 2023